Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma

Journal: Nature Communications

Published: 2019-07-15

DOI: 10.1038/s41467-019-10898-3

Affiliations: 40

Authors: 98

Go to article
Institutions Share
MRC Cancer Unit, University of Cambridge, United Kingdom (UK) 0.21
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.08
School of Cancer and Pharmaceutical Sciences, KCL, United Kingdom (UK) 0.04
Cambridge University Hospitals NHS Foundation Trust, United Kingdom (UK) 0.04
Nottingham University Hospitals NHS Trust (NUH), United Kingdom (UK) 0.04
Royal Surrey County Hospital NHS Trust, United Kingdom (UK) 0.03
Gloucestershire Royal Hospital (GRH), GHNHSFT, United Kingdom (UK) 0.03
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK) 0.03
King's College London (KCL), United Kingdom (UK) 0.03
Norfolk and Norwich University Hospitals NHS Foundation Trust, United Kingdom (UK) 0.03
Plymouth Hospitals NHS Trust, United Kingdom (UK) 0.03
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK) 0.03
Department of Surgery and Cancer, ICL, United Kingdom (UK) 0.03
Computational and Systems Biology Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.03
Royal Infirmary of Edinburgh, United Kingdom (UK) 0.03
University College London (UCL), United Kingdom (UK) 0.02
University Hospitals Coventry and Warwickshire NHS Trust, United Kingdom (UK) 0.02
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.02
Centre for Cancer Research and Cell Biology (CCRCB), QUB, United Kingdom (UK) 0.02
BHRUT Queen's Hospital, United Kingdom (UK) 0.02
Department of Histopathology and Cytology, Addenbrooke's Hospital, United Kingdom (UK) 0.02
Oxford Department of Computer Science, United Kingdom (UK) 0.02
The University of Edinburgh, United Kingdom (UK) 0.02
Centre for Gastrointestinal Sciences, UoM, United Kingdom (UK) 0.01
Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, United Kingdom (UK) 0.01
Cancer Sciences Academic Unit, Soton, United Kingdom (UK) 0.01
Italian Institute for Genomic Medicine (IIGM), Italy 0.01
High Throughput Screening Laboratory (HTS), The Francis Crick Institute, United Kingdom (UK) 0.01
Norfolk and Waveney Cellular Pathology Network, United Kingdom (UK) 0.01
Wythenshawe Hospital, MFT, United Kingdom (UK) 0.01
University of Birmingham (UB), United Kingdom (UK) 0.01
Salford Royal NHS Foundation Trust, United Kingdom (UK) 0.01
The University of Nottingham (UoN), United Kingdom (UK) 0.01
Queen's Medical Centre (QMC), NUH, United Kingdom (UK) 0.01
Cancer Epigenetics Laboratory, The Francis Crick Institute, United Kingdom (UK) 0.01
Institute of Cancer and Genomic Sciences, UB, United Kingdom (UK) 0.01
UCL Cancer Institute, United Kingdom (UK) 0.01
Faculty of Medical and Human Sciences, UoM, United Kingdom (UK) 0.01
Heart of England NHS Foundation Trust, United Kingdom (UK) 0.01
Wrightington, Wigan and Leigh NHS Foundation Trust (WWLNHS), United Kingdom (UK) 0

Return